NutriBand (NTRB) Depreciation & Amortization (CF) (2017 - 2026)
NutriBand's (NTRB) quarterly Depreciation & Amortization (CF) came in at $35879.0 in Q1 2026, down 50.75% year-on-year from $72855.0 in Q1 2025, and down 16.47% quarter-over-quarter from $42956.0 in Q4 2025.
NutriBand (NTRB) Depreciation & Amortization (CF) (2017 - 2026) Analysis & Trends
NutriBand has disclosed Depreciation & Amortization (CF) across 10 years of filings, most recently posting $35879.0 for Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $35879.0, down 50.75% year-over-year; the trailing twelve-month figure through Jan 2026 was $193697.0 (down 32.05% YoY), and the FY2026 annual result was $193797.0, down 32.01% from the prior year.
- Depreciation & Amortization (CF) came in at $35879.0 for Q1 2026 at NutriBand, down from $42956.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $99779.0 in Q4 2022 to a low of $35879.0 in Q1 2026.
- The 5-year median for Depreciation & Amortization (CF) is $72855.0 (2025), against an average of $68822.2.
- Across the five-year window, Depreciation & Amortization (CF) grew 25.42% in 2022 and plunged 50.75% in 2026, its largest moves.
- NutriBand's Depreciation & Amortization (CF) stood at $99779.0 in 2022, then sank by 31.98% to $67871.0 in 2023, then increased by 7.78% to $73149.0 in 2024, then sank by 41.28% to $42956.0 in 2025, then declined by 16.47% to $35879.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $35879.0 (Q1 2026), $42956.0 (Q4 2025), and $57382.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 1,395.22 |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 429,663.65 |
| 10 | NutriBand | 41.21 Mn | 36.63 Mn | 88,941.00 | 35,879.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 35,879.00 |
| Jan 31, 2026 | 35,879.00 |
| Oct 31, 2025 | 42,956.00 |
| Oct 31, 2025 | 42,956.00 |
| Jul 31, 2025 | 57,382.00 |
| Jul 31, 2025 | 57,382.00 |
| Apr 30, 2025 | 57,480.00 |
| Apr 30, 2025 | 57,480.00 |
| Jan 31, 2025 | 72,855.00 |
| Jan 31, 2025 | 72,855.00 |
| Oct 31, 2024 | 73,149.00 |
| Oct 31, 2024 | 73,149.00 |
| Jul 31, 2024 | 69,949.00 |
| Jul 31, 2024 | 69,949.00 |
| Apr 30, 2024 | 69,101.00 |
| Apr 30, 2024 | 69,101.00 |
| Jan 31, 2024 | 69,340.00 |
| Jan 31, 2024 | 69,340.00 |
| Oct 31, 2023 | 67,871.00 |
| Oct 31, 2023 | 67,871.00 |